Two other women (39 years old, Hodgkin’s lymphoma, and 38 years old, malignant melanoma) reported spontaneous abortion about one year and two years after the end of anti-PD-1 monotherapy with nivolumab and pembrolizumab, respectively. Here, PDCD1 is linked to melanoma.